DeepMed Research

Sino Medical Sciences Technology Inc.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis

Not Applicable

Recruiting

Conditions: Intracranial Atherosclerotic Stenosis

First Posted Date: 2025-03-25

Last Posted Date: 2025-04-01

Lead Sponsor: Sino Medical Sciences Technology Inc.

Target Recruit Count: 300

Registration Number: NCT06857058

Locations: 🇨🇳
The first affiliated hospital of zhengzhou university, Zhengzhou, China

Comparison Three Vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation

Not Applicable

Recruiting

Conditions: Intracranial Arteriosclerosis
Intracranial Artery Stenosis
Drug-Eluting Stents

First Posted Date: 2025-03-25

Last Posted Date: 2025-04-01

Lead Sponsor: Sino Medical Sciences Technology Inc.

Target Recruit Count: 478

Registration Number: NCT06857045

Locations: 🇨🇳
The Fourth Affiliated Hospital of China Medical University, Ha'erbin, China

A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China

Not Applicable

Recruiting

Conditions: Intracranial Artery Stenosis
Stenosis Artery
Drug-Eluting Stents
Intracranial Arteriosclerosis

Interventions: Device: Drug-Eluting Stents

First Posted Date: 2023-01-20

Last Posted Date: 2025-04-01

Lead Sponsor: Sino Medical Sciences Technology Inc.

Target Recruit Count: 1000

Registration Number: NCT05692882

Locations: 🇨🇳
Ganzhou People's Hospital, Ganzhou, China
🇨🇳
The First Affiliated Hospital of Ningbo University, Ningbo, China
🇨🇳
First People's Hospital of Chenzhou, Chenzhou, China

and more 2 locations

Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease

Not Applicable

Completed

Conditions: Coronary Stenosis
Coronary Artery Stenosis
In-stent Restenosis

Interventions: Device: SINOMED CBC
Device: NSE Coronary Dilatation Catheter

First Posted Date: 2022-08-22

Last Posted Date: 2024-03-04

Lead Sponsor: Sino Medical Sciences Technology Inc.

Target Recruit Count: 136

Registration Number: NCT05509296

Locations: 🇨🇳
Peking University First Hospital, Beijing, China
🇨🇳
Peking University Third Hospital, Beijing, China
🇨🇳
Kaifeng Central Hospital, Kaifeng, China

and more 5 locations

A Study to Evaluate the Impact of 11-month Ticagrelor Monotherapy Following One-month DAPT After PCI

Not Applicable

Withdrawn

Conditions: Coronary Artery Disease

Interventions: Device: HT Supreme

First Posted Date: 2021-08-20

Last Posted Date: 2024-04-25

Lead Sponsor: Sino Medical Sciences Technology Inc.

Registration Number: NCT05015699

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

Not Applicable

Active, not recruiting

Conditions: Coronary Artery Disease

Interventions: Device: Xience or Promus DES
Device: BuMA Supreme DES

First Posted Date: 2017-05-30

Last Posted Date: 2021-02-16

Lead Sponsor: Sino Medical Sciences Technology Inc.

Target Recruit Count: 1632

Registration Number: NCT03168776

Locations: 🇨🇦
Foothills Medical Centre, Calgary, Alberta, Canada
🇯🇵
Shonan Kamakura General Hospital, Kanagawa, Kamakura City, Japan
🇳🇱
Amsterdam UMC, Amsterdam, Netherlands

and more 55 locations

A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT

Not Applicable

Completed

Conditions: Coronary Artery Disease
Unstable Angina Pectoris
Stable Angina Pectoris

Interventions: Device: BuMA Supreme™ stent
Device: Xience V/Prime stent

First Posted Date: 2016-04-21

Last Posted Date: 2021-10-13

Lead Sponsor: Sino Medical Sciences Technology Inc.

Target Recruit Count: 82

Registration Number: NCT02747329

Locations: 🇨🇳
The PLA General Hospital, BeiJing, Beijing, China

A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Not Applicable

Active, not recruiting

Conditions: Coronary Artery Disease

Interventions: Device: BuMA Supreme

First Posted Date: 2016-03-04

Last Posted Date: 2024-04-25

Lead Sponsor: Sino Medical Sciences Technology Inc.

Target Recruit Count: 1000

Registration Number: NCT02698852

Locations: 🇨🇳
Zhongshan Hospital, Shanghai, China

A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Not Applicable

Active, not recruiting

Conditions: Coronary Artery Disease

Interventions: Device: BuMA™
Device: BuMA Supreme

First Posted Date: 2016-03-04

Last Posted Date: 2024-04-25

Lead Sponsor: Sino Medical Sciences Technology Inc.

Target Recruit Count: 539

Registration Number: NCT02698839

Locations: 🇨🇳
Zhongshan Hospital, Shanghai, China

First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent (NOVA Trial)

Not Applicable

Completed

Conditions: Ischemic Stroke

Interventions: Device: Apollo Intracranial Stent System
Device: NOVA Intracranial Sirolimus Eluting Stent System

First Posted Date: 2015-10-16

Last Posted Date: 2021-10-13

Lead Sponsor: Sino Medical Sciences Technology Inc.

Target Recruit Count: 272

Registration Number: NCT02578069

Locations: 🇨🇳
Beijing Tiantan Hospital, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy